The largest price increases came from Leadiant Pharmaceuticals, a subsidiary of Italy-based Essetifin. Leadiant raised prices ...

DelveInsight's Inflammatory Bowel disease market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...

CNBC’s Jim Cramer delivers his daily Mad Dash. SEC Sues Elon Musk Over Twitter Purchase. Spain is planning a radical fix for its housing crisis: A 100% tax on non-EU buyers TSA Issues Final Rule ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

The analysts valued the Alzheimer’s market across the U.S., France, Germany, Italy, Spain ... Eisai and Biogen, with Leqembi, and Eli Lilly, with Kisunla, have begun the process of establishing ...

Patel, Trump’s nominee to be FBI director, was paid $25,000 last year by a film company that has promoted anti-Western views ...

Eli Lilly will provide the total funding ... Leonardo's Brancati discusses Italy's military space cloud leveraging AI and supercomputing “In the future, space technology is expected to expand ...

The launch of these products and two other anti-Aβ targeting drugs, Eli Lilly’s remternetug and Alzheon’s ALZ-801 (valiltramiprosate), during the forecast period will be a significant driver ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.